Welcome to our dedicated page for Gencor Industres SEC filings (Ticker: GENC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Gencor Industries, Inc. filings document operating results, governance matters, capital structure, and material events for a manufacturer of highway-construction equipment and environmental control equipment. Form 8-K reports include financial-results releases, leadership changes, auditor changes, annual meeting scheduling, shareholder votes, and control-related disclosures.
The company’s proxy materials describe director elections, auditor ratification, advisory compensation votes, and voting mechanics for common stock and Class B stock. Its disclosures identify GENC common stock listed on NYSE American and describe Class B stock provisions that affect board elections. Filing topics also include internal-control and audit-related matters, beneficial ownership, and formal records of board and shareholder actions.
Gencor Industries (NYSE:GENC) filed its overdue Annual Report for FY ended September 30 2024. The filing reveals two auditor changes: MSL partners joined Forvis Mazars on Nov 1 2024; Forvis Mazars was then dismissed on Feb 13 2025 and replaced by Berkowitz Pollack Brant on Feb 20 2025. Auditor turnover delayed completion of the FY 2024 audit and ICFR attestation, resulting in late Form 10-K and outstanding Form 10-Qs for the quarters ended Dec 31 2024 and Mar 31 2025.
Consequently, the company received a NYSE American delinquency notice. The exchange has now granted an extension until August 19 2025 to file all missing reports and regain compliance, mitigating immediate delisting risk.
Capital structure: as of June 25 2025 the company had 12.34 M common shares and 2.32 M Class B shares outstanding; non-affiliate market value at Q2 FY24 was $160.2 million.
No restatements, going-concern warnings, or material changes to business operations were disclosed in this report.
Gencor Industries (NYSE:GENC) filed its overdue Annual Report for FY ended September 30 2024. The filing reveals two auditor changes: MSL partners joined Forvis Mazars on Nov 1 2024; Forvis Mazars was then dismissed on Feb 13 2025 and replaced by Berkowitz Pollack Brant on Feb 20 2025. Auditor turnover delayed completion of the FY 2024 audit and ICFR attestation, resulting in late Form 10-K and outstanding Form 10-Qs for the quarters ended Dec 31 2024 and Mar 31 2025.
Consequently, the company received a NYSE American delinquency notice. The exchange has now granted an extension until August 19 2025 to file all missing reports and regain compliance, mitigating immediate delisting risk.
Capital structure: as of June 25 2025 the company had 12.34 M common shares and 2.32 M Class B shares outstanding; non-affiliate market value at Q2 FY24 was $160.2 million.
No restatements, going-concern warnings, or material changes to business operations were disclosed in this report.
Gencor Industries (NYSE:GENC) filed an 8-K under Item 2.02 – Results of Operations and Financial Condition on 27 Jun 2025, furnishing its FY-2024 and Q4-2024 earnings press release as Exhibit 99.1. The information is deemed “furnished,” limiting Section 18 liability, and is not incorporated into other filings unless later referenced. No additional items, financial statements or strategic updates were included. Investors should consult Exhibit 99.1 for detailed revenue, profit and cash-flow figures.
Gencor Industries (NYSE:GENC) filed an 8-K under Item 2.02 – Results of Operations and Financial Condition on 27 Jun 2025, furnishing its FY-2024 and Q4-2024 earnings press release as Exhibit 99.1. The information is deemed “furnished,” limiting Section 18 liability, and is not incorporated into other filings unless later referenced. No additional items, financial statements or strategic updates were included. Investors should consult Exhibit 99.1 for detailed revenue, profit and cash-flow figures.
Gencor Industries (NYSE:GENC) filed an 8-K (Item 3.01) announcing it remains non-compliant with NYSE American listing standards because its FY-2024 Form 10-K and two Form 10-Qs are still delinquent. The exchange has accepted the company’s plan and granted an extension to August 19 2025; the final 12-month cure deadline is December 30 2025. Failure to meet interim milestones or the ultimate deadline will trigger delisting proceedings. Management "expects" to file the 10-K by June 30 2025 and the outstanding 10-Qs by the new cure date but gives no assurance. A press release (Ex. 99.1) and forward-looking statements outlining geopolitical and supply-chain risks accompany the filing.
Gencor Industries (NYSE:GENC) filed an 8-K (Item 3.01) announcing it remains non-compliant with NYSE American listing standards because its FY-2024 Form 10-K and two Form 10-Qs are still delinquent. The exchange has accepted the company’s plan and granted an extension to August 19 2025; the final 12-month cure deadline is December 30 2025. Failure to meet interim milestones or the ultimate deadline will trigger delisting proceedings. Management "expects" to file the 10-K by June 30 2025 and the outstanding 10-Qs by the new cure date but gives no assurance. A press release (Ex. 99.1) and forward-looking statements outlining geopolitical and supply-chain risks accompany the filing.